http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-4097109-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f8179d07d2366fdab43b0895c2984d09
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D489-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D498-12
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D498-12
filingDate 2021-01-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_633e1b11e3b0cd72bceee5d703fe026d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_06523ced3062f738ee2265c881106de4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d801de86439c6bb3a148506f15c9e405
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8ec12e4006823349d6d34225e1733ef3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b482145d31990b448a329f5e5b5580a7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2e531f0bbeab18a636ed102863589e56
publicationDate 2022-12-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-4097109-A1
titleOfInvention Process for the synthesis of buprenorphine
abstract The present invention relates to a novel route of synthesis for the opioid receptor antagonist Buprenorphine or a pharmaceutically acceptable salt thereof, starting from thebaine, wherein the route comprises the reaction of the baine with a dienophile; forming an alkylated reaction product by reaction with a Grignard-reagent; formation of an cyanamide; deprotection of the cyanamide- and the phenolic-oxygen-moiety, wherein the cleavage of one or both groups is performed in the presence of an alkali or alkaline earth sulfide; followed by derivatization with a cyclopropyl-halogen and hydrogenation to yield Buprenorphine.
priorityDate 2020-01-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5565
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5288826
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226405826
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID166681271
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID476389677
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5324289
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395290
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8150
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393451
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226423334
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID644073
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226406100
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394385
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394566
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9848990
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226406099
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226474085
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID22238780
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID81531
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID17986852

Total number of triples: 37.